000875388 001__ 875388
000875388 005__ 20210130004926.0
000875388 0247_ $$2doi$$a10.1007/s12311-020-01130-w
000875388 0247_ $$2pmid$$apmid:32338350
000875388 0247_ $$2ISSN$$a1473-4222
000875388 0247_ $$2ISSN$$a1473-4230
000875388 0247_ $$2Handle$$a2128/25307
000875388 0247_ $$2WOS$$aWOS:000528986700001
000875388 037__ $$aFZJ-2020-01999
000875388 041__ $$aeng
000875388 082__ $$a610
000875388 1001_ $$0P:(DE-HGF)0$$aIhl, Thomas$$b0
000875388 245__ $$aInvestigation of Visual System Involvement in Spinocerebellar Ataxia Type 14.
000875388 260__ $$aLondon$$bDunitz$$c2020
000875388 3367_ $$2DRIVER$$aarticle
000875388 3367_ $$2DataCite$$aOutput Types/Journal article
000875388 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1595004730_26338
000875388 3367_ $$2BibTeX$$aARTICLE
000875388 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000875388 3367_ $$00$$2EndNote$$aJournal Article
000875388 520__ $$aSpinocerebellar ataxia type 14 (SCA-PRKCG, formerly SCA14) is a rare, slowly progressive disorder caused by conventional mutations in protein kinase Cγ (PKCγ). The disease usually manifests with ataxia, but previous reports suggested PRKCG variants in retinal pathology. To systematically investigate for the first time visual function and retinal morphology in patients with SCA-PRKCG. Seventeen patients with PRKCG variants and 17 healthy controls were prospectively recruited, of which 12 genetically confirmed SCA-PRKCG patients and 14 matched controls were analyzed. We enquired a structured history for visual symptoms. Vision-related quality of life was obtained with the National Eye Institute Visual Function Questionnaire (NEI-VFQ) including the Neuro-Ophthalmic Supplement (NOS). Participants underwent testing of visual acuity, contrast sensitivity, visual fields, and retinal morphology with optical coherence tomography (OCT). Measurements of the SCA-PRKCG group were analyzed for their association with clinical parameters (ataxia rating and disease duration). SCA-PRKCG patients rate their vision-related quality of life in NEI-VFQ significantly worse than controls. Furthermore, binocular visual acuity and contrast sensitivity were worse in SCA-PRKCG patients compared with controls. Despite this, none of the OCT measurements differed between groups. NEI-VFQ and NOS composite scores were related to ataxia severity. Additionally, we describe one patient with a genetic variant of uncertain significance in the catalytic domain of PKCγ who, unlike all confirmed SCA-PRKCG, presented with a clinically silent epitheliopathy. SCA-PRKCG patients had reduced binocular vision and vision-related quality of life. Since no structural retinal damage was found, the pathomechanism of these findings remains unclear.
000875388 536__ $$0G:(DE-HGF)POF3-571$$a571 - Connectivity and Activity (POF3-571)$$cPOF3-571$$fPOF III$$x0
000875388 588__ $$aDataset connected to CrossRef, PubMed,
000875388 7001_ $$0P:(DE-HGF)0$$aKadas, Ella M$$b1
000875388 7001_ $$0P:(DE-HGF)0$$aOberwahrenbrock, Timm$$b2
000875388 7001_ $$0P:(DE-HGF)0$$aEndres, Matthias$$b3
000875388 7001_ $$0P:(DE-HGF)0$$aKlockgether, Thomas$$b4
000875388 7001_ $$0P:(DE-HGF)0$$aSchroeter, Jan$$b5
000875388 7001_ $$0P:(DE-HGF)0$$aBrandt, Alexander U$$b6
000875388 7001_ $$0P:(DE-HGF)0$$aPaul, Friedemann$$b7
000875388 7001_ $$0P:(DE-Juel1)131622$$aMinnerop, Martina$$b8
000875388 7001_ $$0P:(DE-HGF)0$$aDoss, Sarah$$b9
000875388 7001_ $$0P:(DE-HGF)0$$aSchmitz-Hübsch, Tanja$$b10
000875388 7001_ $$0P:(DE-HGF)0$$aZimmermann, Hanna G$$b11$$eCorresponding author
000875388 773__ $$0PERI:(DE-600)2071266-2$$a10.1007/s12311-020-01130-w$$p469-482$$tThe Cerebellum$$v19$$x1473-4230$$y2020
000875388 8564_ $$uhttps://juser.fz-juelich.de/record/875388/files/Ihl_etal_Cerebellum_2020.pdf$$yOpenAccess
000875388 8564_ $$uhttps://juser.fz-juelich.de/record/875388/files/Ihl_etal_Cerebellum_2020.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000875388 909CO $$ooai:juser.fz-juelich.de:875388$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000875388 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131622$$aForschungszentrum Jülich$$b8$$kFZJ
000875388 9131_ $$0G:(DE-HGF)POF3-571$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vConnectivity and Activity$$x0
000875388 9141_ $$y2020
000875388 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000875388 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000875388 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000875388 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCEREBELLUM : 2017
000875388 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000875388 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000875388 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000875388 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000875388 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000875388 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000875388 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000875388 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000875388 9201_ $$0I:(DE-Juel1)INM-1-20090406$$kINM-1$$lStrukturelle und funktionelle Organisation des Gehirns$$x0
000875388 980__ $$ajournal
000875388 980__ $$aVDB
000875388 980__ $$aUNRESTRICTED
000875388 980__ $$aI:(DE-Juel1)INM-1-20090406
000875388 9801_ $$aFullTexts